1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints
- Author
- [email protected] (Vinay Prasad, MD MPH)
- Published
- Thu 20 Sep 2018
- Episode Link
- https://soundcloud.com/plenarysession/109-response-rate-in-phase-i-trials-jacob-and-mi-stroke-and-metastasis-as-hard-endpoints
Special episode! We discuss the recent correspondence in NEJM on response rate in phase I clinical trials, the JACOB trial published in The Lancet Oncology on pertuzumab for HER2-positive gastric cancer, and we give an evaluation of MI, stroke, and metastasis as hard endpoints.
